I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 24% ± 8% | |
| epithelial cell | 3 studies | 19% ± 2% | |
| GABAergic neuron | 3 studies | 24% ± 5% | |
| glutamatergic neuron | 3 studies | 31% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 24% ± 8% | |
| epithelial cell | 3 studies | 19% ± 2% | |
| GABAergic neuron | 3 studies | 24% ± 5% | |
| glutamatergic neuron | 3 studies | 31% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 597.22 | 1444 / 1445 | 99% | 8.65 | 182 / 183 |
| breast | 100% | 618.90 | 458 / 459 | 98% | 11.01 | 1094 / 1118 |
| stomach | 100% | 645.55 | 359 / 359 | 95% | 6.73 | 272 / 286 |
| prostate | 100% | 694.35 | 245 / 245 | 95% | 6.07 | 477 / 502 |
| brain | 99% | 393.18 | 2615 / 2642 | 96% | 5.44 | 677 / 705 |
| lung | 97% | 389.50 | 563 / 578 | 97% | 6.27 | 1126 / 1155 |
| intestine | 100% | 587.35 | 964 / 966 | 94% | 6.24 | 498 / 527 |
| bladder | 100% | 554.86 | 21 / 21 | 92% | 5.75 | 466 / 504 |
| pancreas | 100% | 528.35 | 328 / 328 | 88% | 3.83 | 157 / 178 |
| uterus | 100% | 484.03 | 170 / 170 | 88% | 5.68 | 402 / 459 |
| kidney | 100% | 488.16 | 89 / 89 | 87% | 4.44 | 783 / 901 |
| ovary | 100% | 518.69 | 180 / 180 | 83% | 3.95 | 359 / 430 |
| skin | 100% | 611.46 | 1805 / 1809 | 84% | 4.30 | 395 / 472 |
| thymus | 100% | 648.38 | 653 / 653 | 83% | 3.52 | 504 / 605 |
| liver | 100% | 566.16 | 226 / 226 | 71% | 3.05 | 287 / 406 |
| adrenal gland | 100% | 880.37 | 258 / 258 | 48% | 1.70 | 111 / 230 |
| spleen | 100% | 359.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.07 | 1 / 1 |
| adipose | 100% | 460.92 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 402.77 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 95% | 263.47 | 765 / 803 | 0% | 0 | 0 / 0 |
| heart | 92% | 305.70 | 792 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 6.25 | 39 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 1.69 | 13 / 29 |
| eye | 0% | 0 | 0 / 0 | 44% | 1.60 | 35 / 80 |
| peripheral blood | 29% | 258.23 | 269 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000467 | Biological process | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
| GO_0003676 | Molecular function | nucleic acid binding |
| Gene name | ERI2 |
| Protein name | ERI1 exoribonuclease family member 2 ERI1 exoribonuclease 2 (EC 3.1.-.-) (Exonuclease domain-containing protein 1) |
| Synonyms | KIAA1504 EXOD1 |
| Description | |
| Accessions | A8K979 ENST00000569729.5 [A8K979-3] H3BN77 ENST00000357967.9 [A8K979-1] ENST00000568805.5 ENST00000300005.7 [A8K979-4] ENST00000564349.5 [A8K979-2] ENST00000563117.5 [A8K979-2] |
